These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2434738)

  • 1. Effects of simultaneous administration of mexiletine and quinidine on the electrophysiologic parameters of canine Purkinje fibers.
    Burke GH; Loukides JE; Berman ND
    J Cardiovasc Pharmacol; 1986; 8(6):1138-43. PubMed ID: 2434738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative electropharmacology of mexiletine, lidocaine and quinidine in a canine Purkinje fiber model.
    Burke GH; Loukides JE; Berman ND
    J Pharmacol Exp Ther; 1986 Apr; 237(1):232-6. PubMed ID: 3958966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
    Roden DM; Iansmith DH; Woosley RL
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
    Costard-Jäckle A; Franz MR
    J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the cellular electrophysiology of mexiletine and sotalol, singly and combined, in canine Purkinje fibers.
    Berman ND; Loukides JE
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):286-92. PubMed ID: 2464100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular electropharmacology of the simultaneous administration of propranolol and mexiletine: a class I and II antiarrhythmic drug combination.
    Berman ND; Loukides JE
    J Electrocardiol; 1987 Nov; 20(5):297-302. PubMed ID: 3430100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency-dependent effects of several class I antiarrhythmic drugs on Vmax of action potential upstroke in canine cardiac Purkinje fibers.
    Varro A; Elharrar V; Surawicz B
    J Cardiovasc Pharmacol; 1985; 7(3):482-92. PubMed ID: 2410678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of the electrophysiologic effects of mexiletine in canine Purkinje fibers alters the response to subsequent hypoxia.
    Berman ND; Ogilvie RI; Loukides JE
    Can J Physiol Pharmacol; 1987 Oct; 65(10):2104-9. PubMed ID: 3427544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential electrophysiologic effects of mexiletine on normal and hypoxic canine Purkinje fibers.
    Burke GH; Berman ND
    J Cardiovasc Pharmacol; 1985; 7(6):1096-100. PubMed ID: 2418294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antiarrhythmic drugs on the premature action potential duration in canine cardiac Purkinje fibers.
    Varro A; Elharrar V; Surawicz B
    J Pharmacol Exp Ther; 1985 May; 233(2):304-11. PubMed ID: 3999021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of quinidine in the mexiletine-quinidine interaction: electrophysiologic correlates of enhanced antiarrhythmic efficacy.
    Duff HJ; Rahmberg M; Sheldon RS
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):685-92. PubMed ID: 1703588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency-dependent effect of quinidine, mexiletine, and their combination on postrepolarization refractoriness in vivo.
    Costard-Jaeckle A; Liem LB; Franz MR
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):810-7. PubMed ID: 2481766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electropharmacologic synergism with mexiletine and quinidine.
    Duff HJ; Kolodgie FD; Roden DM; Woosley RL
    J Cardiovasc Pharmacol; 1986; 8(4):840-6. PubMed ID: 2427827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of the frequency- and voltage-dependent effects of quinidine when administered in combination with tocainide in canine Purkinje fibers.
    Valois M; Sasyniuk BI
    Circulation; 1987 Aug; 76(2):427-41. PubMed ID: 2440617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic interactions between mexiletine-quinidine and mexiletine-ropitoin in guinea pig papillary muscle.
    Valenzuela C; Sanchez-Chapula J
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):783-9. PubMed ID: 2481194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological actions of mexiletine (Kö1173) on canine Purkinje fibres and ventricular muscle.
    Arita M; Goto M; Nagamoto Y; Saikawa T
    Br J Pharmacol; 1979 Sep; 67(1):143-52. PubMed ID: 497518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative electrophysiologic effects of metabolites of quinidine and hydroquinidine.
    Fautrez VM; Adamantidis MM; Caron JF; Libersa CC; Dupuis BA
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):308-18. PubMed ID: 1378107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antiarrhythmic drugs on premature action potential duration in canine ventricular muscle fibers.
    Varro A; Saitoh H; Surawicz B
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):407-14. PubMed ID: 2444793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibers.
    Nattel S; Zeng FD
    J Pharmacol Exp Ther; 1984 Apr; 229(1):283-91. PubMed ID: 6707943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.